JP2005508323A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508323A5
JP2005508323A5 JP2003530220A JP2003530220A JP2005508323A5 JP 2005508323 A5 JP2005508323 A5 JP 2005508323A5 JP 2003530220 A JP2003530220 A JP 2003530220A JP 2003530220 A JP2003530220 A JP 2003530220A JP 2005508323 A5 JP2005508323 A5 JP 2005508323A5
Authority
JP
Japan
Prior art keywords
ifn
pharmaceutical composition
paclitaxel
carboplatin
chemotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003530220A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508323A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/030621 external-priority patent/WO2003026581A2/en
Publication of JP2005508323A publication Critical patent/JP2005508323A/ja
Publication of JP2005508323A5 publication Critical patent/JP2005508323A5/ja
Withdrawn legal-status Critical Current

Links

JP2003530220A 2001-09-26 2002-09-26 癌治療のための医薬組成物及び方法 Withdrawn JP2005508323A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32524601P 2001-09-26 2001-09-26
PCT/US2002/030621 WO2003026581A2 (en) 2001-09-26 2002-09-26 Pharmaceutical compositions and methods for treating cancer

Publications (2)

Publication Number Publication Date
JP2005508323A JP2005508323A (ja) 2005-03-31
JP2005508323A5 true JP2005508323A5 (enExample) 2006-01-05

Family

ID=23267053

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003530220A Withdrawn JP2005508323A (ja) 2001-09-26 2002-09-26 癌治療のための医薬組成物及び方法

Country Status (5)

Country Link
US (1) US20040191218A1 (enExample)
EP (1) EP1435965A4 (enExample)
JP (1) JP2005508323A (enExample)
AU (1) AU2002337713A1 (enExample)
WO (1) WO2003026581A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080213399A1 (en) * 2005-02-03 2008-09-04 Topotarget Uk Limited Combination Therapies Using Hdac Inhibitors
DK2073837T3 (da) * 2006-10-06 2014-09-29 Bavarian Nordic Inc Rekombinant modificeret vaccinia-ankara-virus, der koder for et her-2-antigen, i kombination med en taxan til anvendelse til behandling af cancer
RU2346692C2 (ru) * 2007-03-29 2009-02-20 Ефаг АО Применение 9-оксоакридин-10-уксусной кислоты, ее солей и сложных эфиров в комбинированной терапии рака яичников, способ лечения и наборы
CA2966216A1 (en) * 2014-11-14 2016-05-19 Genentech, Inc. Predicting response to a vegf antagonist
CN108143714A (zh) * 2016-04-12 2018-06-12 夏建明 一种用于治疗晚期卵巢癌的注射液及其制备方法
CN105726475B (zh) * 2016-04-12 2018-05-04 青岛市妇女儿童医院 一种治疗晚期卵巢癌的注射液及其制备方法
EP4571309A1 (en) * 2022-08-10 2025-06-18 Nihon University Sample test method, test kit for gynecological cancer and precancerous lesion thereof, and medicine
JP7716691B2 (ja) * 2022-08-10 2025-08-01 学校法人日本大学 試料の検査方法、婦人科癌及びその前癌病変の検査キット及び医薬

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588505A5 (enExample) * 1972-06-08 1977-06-15 Research Corp
US4657927A (en) * 1978-05-04 1987-04-14 Research Corporation Malonato platinum compounds
US4942184A (en) * 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol
US5440056A (en) * 1992-04-17 1995-08-08 Abbott Laboratories 9-deoxotaxane compounds
CA2086874E (en) * 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.

Similar Documents

Publication Publication Date Title
JP2007515469A5 (enExample)
JP2012506448A5 (enExample)
RU2010133489A (ru) Применение ингибиторов гамма-секретазы для лечения рака
RU2017132877A (ru) Комбинация антагониста pd-1 и эрибулина для лечения рака
RU2012106620A (ru) Комбинации и способы введения терапевтических средств и комбинированной терапии
JP2012067116A5 (enExample)
JP2006515883A5 (enExample)
PT2127652E (pt) Agente libertador da hormona estimuladora dos folículos
RU2004115110A (ru) Улучшенная схема применения противоопухолевого соединения в терапии рака
JP2011140521A (ja) タキサンにより惹起される神経毒性を予防又は軽減するための薬剤
JP2020523356A5 (enExample)
JP2014511383A5 (enExample)
RU2008138560A (ru) Улучшенные способы лечения опухолей
JP2017516802A5 (enExample)
RU2005141408A (ru) Комбинированное применение эктеинасцидина-743 и содержащих платину противоопухолевых соединений
JP2009539994A5 (enExample)
JP2018531605A5 (enExample)
JP2005508323A5 (enExample)
JP2008540364A5 (enExample)
Kobayashi et al. Pharmacokinetic study of weekly administration dose of paclitaxel in patients with advanced or recurrent gastric cancer in Japan
JP2005525409A5 (enExample)
JP2006514681A5 (enExample)
JP2008517991A5 (enExample)
CA2435921A1 (en) Method of cancer therapy
JP2009539916A5 (enExample)